Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,339 public trials 1,980 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, Not Recruiting

A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)

NCT04546009

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer, +4 more
Locations
  • Orange Coast Memorial Medical Center Fountain Valley, California, United States
  • Long Beach Memorial Medical Center Long Beach, California, United States
  • Kaiser Permanente - San Leandro Medical Center San Leandro, California, United States
  • Stanford Univ Medical Center Stanford, California, United States
View all 256 locations
View Trial Details
Active, Not Recruiting

Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

NCT06760637

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
Locations
  • The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Hospital Birmingham, Alabama, United States
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
View all 463 locations
View Trial Details
Active, Not Recruiting

ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer

NCT03587740

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • The Stamford Hospital Stamford, Connecticut, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer

NCT05653752

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • BRCR Global Plantation, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Next Oncology-Dallas Irving, Texas, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer

NCT03332797

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 23 locations
View Trial Details

Related conditions